All Stories

  1. Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
  2. Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  3. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: the Neuro-VR study
  4. Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  5. Cognitive profiles across the psychosis continuum
  6. Publisher Correction: Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  7. Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  8. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
  9. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
  10. Brief rapport: Perceptual aberration in patients at ultra‐high risk for psychosis
  11. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
  12. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia
  13. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis
  14. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis
  15. Premorbid functioning in adolescence associates with comorbid disorders in individuals at ultra‐high risk for psychosis: A brief report
  16. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis
  17. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
  18. Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
  19. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
  20. Cortico-cognition Coupling in Treatment Resistant Schizophrenia
  21. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
  22. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis
  23. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra‐high risk for psychosis
  24. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
  25. Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis
  26. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
  27. Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
  28. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
  29. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
  30. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
  31. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
  32. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends
  33. Predictors of remission from the ultra‐high risk state for psychosis
  34. Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC)
  35. Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis
  36. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
  37. Development of Executive Functions as Reflected in Daily Life Behaviors in Young Adults at Ultra-High Risk for Psychosis: Associations With Symptoms and Functioning
  38. Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis
  39. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
  40. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
  41. Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies
  42. T16. GLUTAMATERGIC CHANGES IN UHR
  43. Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
  44. The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
  45. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
  46. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?